Having a wonderful time at the annual Stanford Oncology/Hematology/BMT-CT retreat at Asilomar. Great to see our amazing first year fellows onstage and enjoying fantastic talks including by @ChrisChenMD and @ThomasSunMD Two wonderful days ahead @ShrutiPatelMD@SCIDirector
Excellent study on high-grade NEN genomics (mostly NECs). CDK4/6 mutations very common, TMB > 10% in 20% of pts, expression profile did not segregate well by origin and some CNAs predicted worse outcome, great job @ThomasSunMD@PamelaKunzMD@SukiPaddaMD! https://t.co/0WaWGNkfKO
Physicians are inherently storytellers - witnessing life’s most intimate moments of joy and sorrow through the lens of our patients.
Honored to share a remarkable patient story which had a profound impact on me, published in the JCO.
The Will to Go On:
https://t.co/zbBAIY4vE8
@yone12@SukiPaddaMD If dipnech still present then still at risk for the other nodules to develop into carcinoid tumor. Surveillance is still recommended but the chances are low and can take years.
~10% patients with DIPNECH/tumorlet progressed to pulmonary carcinoid tumor. Just presented our research at #WCLC20. Couldn’t have done it without my mentor Dr. Padda! @SukiPaddaMD
Thanks to NANETS for inviting me to present our DIPNECH research today! Big thanks to the team and my mentors Dr.Kunz and Dr. Padda! @PamelaKunzMD@SukiPaddaMD
@PamelaKunzMD@kate_selig@StanfordDaily Pam you are so brave for speaking out! The article is enlightening and it is already circulating among us residents. The impact will be felt.